Home/Filings/4/0001209191-23-018261
4//SEC Filing

Engelson Erik T. 4

Accession 0001209191-23-018261

CIK 0001652724other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 6:30 PM ET

Size

11.9 KB

Accession

0001209191-23-018261

Insider Transaction Report

Form 4
Period: 2023-03-03
Engelson Erik T.
DirectorPresident and Chief Executive
Transactions
  • Sale

    Common Stock

    2023-03-03$1.03/sh574,666$591,90683,282 total
  • Exercise/Conversion

    Common Stock

    2023-03-03$0.82/sh+574,666$471,226657,948 total
  • Sale

    Common Stock

    2023-03-03$1.09/sh60,000$65,40023,282 total
  • Exercise/Conversion

    Common Stock

    2023-03-03574,6660 total
    Exercise: $0.82Exp: 2029-04-09Common Stock (574,666 underlying)
Holdings
  • Common Stock

    (indirect: See Footnotes)
    46,400
  • Common Stock

    (indirect: See Footnotes)
    191,705
Footnotes (3)
  • [F1]The shares are held by the Elizabeth North Engelson Trust, dated January 17, 2001, for which Mr. Engelson serves as trustee.
  • [F2]The shares are held by Epic Pacific, LLC, of which Mr. Engelson is a Member. Mr. Engelson disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  • [F3]The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option shall vest monthly over the four years from the vesting commencement date.

Issuer

Lucira Health, Inc.

CIK 0001652724

Entity typeother

Related Parties

1
  • filerCIK 0001839384

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 6:30 PM ET
Size
11.9 KB